Explore groundbreaking studies on DNA methylation, histone modifications, and non-coding RNA mechanisms
Discover how the high-dose 13.3 mg/24h rivastigmine transdermal patch is preserving independence in Alzheimer's patients by targeting instrumental activities of daily living (IADLs).